Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001437749-21-029322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-27 | 2021-12-22 | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | M - OptEx | $30.88 | +40.9K | 2.57M | +2% | +$1.26M |
| D | 2021-12-27 | 2021-12-22 | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | F - Tax | $50.16 | -532 | 2.53M | -0.0% | -$26.7K |
| DM | 2021-12-27 | 2021-12-22 | LMAT | LeMaitre George W | COB, CEO, Dir, 10% | M - OptEx | $0.00 | -40.9K | 43 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 41 | $0.00 | 2,525,795 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 2 | Common | Common Stock | 2021-12-22 | F | D | 532 | $50.16 | 2,525,263 | D | — | — | (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 3 | Common | Common Stock | 2021-12-22 | M | A | 11,652 | $31.30 | 2,536,915 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 4 | Common | Common Stock | 2021-12-22 | M | A | 12,746 | $23.56 | 2,549,661 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 5 | Common | Common Stock | 2021-12-22 | M | A | 8,610 | $35.48 | 2,558,271 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 6 | Common | Common Stock | 2021-12-22 | M | A | 7,837 | $37.29 | 2,566,108 | D | — | — | (F3) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 7,837 | $0.00 | 31,345 | D | $37.29 · 2020-12-02 to 2025-12-02 | 7,837 Common Stock | (F5) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. (F9) The expiration date of this option to the extent it is an incentive stock option is 12/2/2025, and the expiration date of this option to the extent it is a nonqualified stock option is 12/2/2027. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 8,610 | $0.00 | 25,830 | D | $35.48 · 2019-12-20 to 2024-12-20 | 8,610 Common Stock | (F5) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. (F8) The expiration date of this option to the extent it is an incentive stock option is 12/20/2024, and the expiration date of this option to the extent it is a nonqualified stock option is 12/20/2026. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 12,746 | $0.00 | 25,494 | D | $23.56 · 2018-12-19 to 2023-12-19 | 12,746 Common Stock | (F5) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. (F7) The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | M | D | 11,652 | $0.00 | 11,652 | D | $31.30 · 2017-12-22 to 2022-12-22 | 11,652 Common Stock | (F5) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. (F6) The expiration date of this option to the extent it is an incentive stock option is 12/22/2022, and the expiration date of this option to the extent it is a nonqualified stock option is 12/22/2024. |
| 11 | Derivative | Dividend Equivalent Rights | 2021-12-22 | M | D | 41 | $0.00 | 43 | D | — · — to — | 41 Common Stock | (F4) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |